P
PASG
Passage Bio, Inc.
5.23
+0.07+1.26%After Hours: 5.22 -0.01 -0.10%17:33 05/22 EDT
OPEN/PREV CLOSE5.20/5.16
TODAY RANGE5.14-5.34
VOL10.97K
MARKET CAP16.76M
52 WEEK RANGE3.935-20.00
AVG VOL (3M)78.72K
% TURNOVER0.34%
TURNOVER--
P/E (TTM)-0.4413
% RANGE3.78%
EPS(TTM)-11.8403
P/E(FORWARD)-0.6054
P/B1.426
BVPS3.664
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP16.69M
SHARES OUTSTANDING3.21M
NEXT EARNINGS08/10-08/14
FREE FLOAT3.19M
LOT SIZE1
EX-DATE07/14/2025
News
Press Releases
Financial Reports
Profile
TipRanks·05/12 19:10
Analysts’ Top Healthcare Picks: Passage Bio (PASG), Esperion (ESPR)
PUBT·05/12 11:10
Passage Bio Q1 FY26 net loss narrows 50.93% to $7.56 million
TipRanks·04/28 11:37
Passage Bio Announces Major Workforce Reduction and Restructuring
Dow Jones·04/21 16:30
Passage Bio Cut to Hold From Buy by TD Cowen
Benzinga·04/21 16:21
TD Cowen Downgrades Passage Bio to Hold
Dow Jones·04/21 16:08
Passage Bio Price Target Cut to $7.00/Share From $21.00 by Chardan Capital
Dow Jones·04/21 16:08
Passage Bio Cut to Neutral From Buy by Chardan Capital
Benzinga·04/21 15:59
Chardan Capital Downgrades Passage Bio to Neutral, Lowers Price Target to $7
TipRanks·04/21 15:56
Wedbush downgrades Passage Bio to Neutral on regulatory uncertainties
TipRanks·04/21 15:23
Passage Bio downgraded to Hold from Buy at TD Cowen